These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 15319087

  • 1. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L, Ashley R, Valaciclovir HSV Transmission Study Group.
    Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HSV shedding.
    Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.
    Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [Abstract] [Full Text] [Related]

  • 6. HSV-2 transmission.
    Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.
    Antiviral Res; 2004 Aug; 63 Suppl 1():S27-35. PubMed ID: 15450383
    [Abstract] [Full Text] [Related]

  • 7. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH, Warren TJ, Ferrera RD, Young DG, Justus SE, Heitman CK, Burroughs SM.
    Mayo Clin Proc; 2006 Oct 15; 81(10):1321-7. PubMed ID: 17036557
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.
    Sex Transm Dis; 2008 Apr 15; 35(4):383-6. PubMed ID: 18362859
    [Abstract] [Full Text] [Related]

  • 14. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, Wendel GD.
    Obstet Gynecol; 2006 Jul 15; 108(1):141-7. PubMed ID: 16816068
    [Abstract] [Full Text] [Related]

  • 15. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH, Warren T, Werner M, Phillips JA.
    Sex Transm Dis; 2007 Jun 15; 34(6):339-43. PubMed ID: 17065847
    [Abstract] [Full Text] [Related]

  • 16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D, Scott LJ, Perry CM.
    Drugs; 2000 Apr 15; 59(4):839-63. PubMed ID: 10804039
    [Abstract] [Full Text] [Related]

  • 17. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L.
    Herpes; 2007 Jun 15; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [Abstract] [Full Text] [Related]

  • 18. Antivirals in the prevention of genital herpes.
    Au E, Sacks SL.
    Herpes; 2002 Dec 15; 9(3):74-7. PubMed ID: 12470605
    [Abstract] [Full Text] [Related]

  • 19. Valacyclovir for the treatment of genital herpes.
    Brantley JS, Hicks L, Sra K, Tyring SK.
    Expert Rev Anti Infect Ther; 2006 Jun 15; 4(3):367-76. PubMed ID: 16771614
    [Abstract] [Full Text] [Related]

  • 20. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
    DeJesus E, Wald A, Warren T, Schacker TW, Trottier S, Shahmanesh M, Hill JL, Brennan CA, Valacyclovir International HSV Study Group.
    J Infect Dis; 2003 Oct 01; 188(7):1009-16. PubMed ID: 14513421
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.